Trial intelligence / Profile preview

Botulinum Toxin Injection Guidance in Stroke Spasticity

NCT02557737Phase 3Unknown

Sponsor
Chang Gung Memorial Hospital
Start
Sep 2012
Primary completion
Jul 2016
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of botulinum toxin type A in spasticity, sponsored by Chang Gung Memorial Hospital. Status: unknown.

02

Drugs

botulinum toxin type A
03

Conditions

spasticity

Beyond the preview

Go deeper on NCT02557737.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02557737.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call